TRANSFORMING CARE FOR PATIENTS IN NEED
Using next-generation enzyme compounds Oxidien develops treatments for
secondary hyperoxaluria to ultimately prevent kidney stone disease.
Oxidien Pharmaceuticals
405 Waltham St. #327
Lexington, MA 02421
TRANSFORMING CARE FOR PATIENTS IN NEED
405 Waltham St. #327
Lexington, MA 02421